Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MedMira Inc
V.MIR
Alternate Symbol(s):
MMIRF
Healthcare
Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid...
diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MIR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Jul 07, 2023 6:00pm
MEDMIRA HAS OVERPROMISED
And undelivered ALL THE NEW THINGS then no follow up It is near the last I will BELIEVE SOMEONE WHO CONTINUALLY SAYS THE CHECK IIN THE MAIL
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Jul 07, 2023 7:53am
😡?— NO FY2023 MATERIAL NEWS
Medmira has three weeks left to come up with some MATERIAL NEWS for. FY2023 otherwise FY2023 results will be available in almost FIVE MONTHS ?
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Jul 05, 2023 2:53pm
Sask and BC studies
Why would anyone choose anything other than the DUAL TEST ?? Why choose just HIV or just SYPHILIS TEST ?
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Comment by
mrmarket1
on Jul 05, 2023 2:23pm
RE:RE:RE:Alberta syphilis trials and Government authorizations
Sask and BC participants have a choice of tests SYPHILIS only HIV only DUAL
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Comment by
mrmarket1
on Jul 05, 2023 2:08pm
RE:RE:Alberta syphilis trials and Government authorizations
He had to be corrected but I’n March 2023 MEDMIRA’s CFO. said Medmira’s.TP(syphilis) antibody “WILL BE the first to be approved in Canada there are Sask and BC study sites
...more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Comment by
mrmarket1
on Jul 05, 2023 1:48pm
RE:Alberta syphilis trials and Government authorizations
Biolytical had its INSTI HIV1/2 SYPHILIS TEST. approved by Health Canada in April 2023 Where is Medmira?? DUAL TESTS seem to be preferred by many in medical articles I have read
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Jul 05, 2023 10:31am
Alberta syphilis trials and Government authorizations
Seems to me INSTI is being favoured in trials Am I missing something about MEDMIRA ???????????????
(5)
•••
conservative2
X
View Profile
View Bullboard History
Post by
conservative2
on Jun 30, 2023 8:11pm
Corporate Update and Financials.
Checking in to see how the stock market responded to the Corporate Update and Financials. it was pretty much as expected. Their is great HOPE for the future and all the prospect of greatness
...more
(9)
•••
august202013
X
View Profile
View Bullboard History
Post by
august202013
on Jun 30, 2023 3:33pm
DON'T BE DISCOURAGED HANG ON
Probably last round of GAME by PETEY78 best friend to flush out HARD CORE MINORITY LONG-TERM SHAREHOLDERS. Pretty sure HC going to issue a PO before November. After that is still none the can
...more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Jun 30, 2023 11:09am
MORE HOPE A DOPE
MORE loss more repitition more secrecy more waiting more grandiosities More opportunities for competitors
(9)
•••
august202013
X
View Profile
View Bullboard History
Post by
august202013
on Jun 30, 2023 6:51am
WRONG AGAIN FRANKFURT CLOSED 0.058
Current quote is 0.095 VS 0.0105 guess was also WRONG in TSX.
(9)
•••
august202013
X
View Profile
View Bullboard History
Post by
august202013
on Jun 30, 2023 1:07am
WATCH FRANKFURT TODAY
Yesterday Frankfurt closed @ 0.065 today should open and close above Euro 0.08. Let's see! Over at TSX believe sellers @ 0.10 should disappear. Haprfully all the sacrifices by
...more
(9)
•••
august202013
X
View Profile
View Bullboard History
Post by
august202013
on Jun 29, 2023 11:46pm
DID NOT HAVE COINS TO BUY UP @ 0.10 TODAY
A clean report card TODAY with SOME CODED messages with are POSITIVE. Now convinced those sellers last week made SOME ERRORS. Let's see tomorrow how institutional investors respond to the 3rd
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 29, 2023 10:01pm
New Press Release - MedMira Reports Third Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / June 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2023.Corporate Update SummaryDuring the third financial quarter of 2023, MedMira continued its focus on its regulatory and clinical trial work for...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden